MedTrace Logo

Social Cognition in Children Treated for a Brain Tumour

NCT01599052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2021-09-01

No results posted yet for this study

Summary

There is ample evidence that children treated for a brain tumour (BT) often develop deficits in social and emotional functioning. The investigators wish to examine the cause of these deficits, i.e. the underlying neuropsychological deficit(s). The aim is to study impairment and developmental delay in social cognition (and related cognitive functions) caused by brain damage in patients treated for a BT in childhood as compared to a reference group of chronically ill children. If we can identify the specific deficits these patients experience, neuropsychological treatment and guidance can be developed to give patients the most optimal chances to live as normal as possible, to improve their quality of life (QoL) and to prevent them from developing depression and anxiety. Eventually, an intervention programme could be developed based on our results, to improve social, vocational and emotional QoL.

Conditions

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • A Kingma, PhD · Unviersity Medical Centre

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01599052 on ClinicalTrials.gov